
About Bioplus Life Sciences
Bioplus Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2004 by Sundeep Aurora. Novel therapeutics and pharmaceutical products are developed and manufactured. It operates on a Professional Services and HealthTech model. Bioplus Life Sciences has raised $29.37 million across 1 funding round from investors including AIF Capital. The company has 553 employees. Bioplus Life Sciences was last valued at $321.18 million in June 2008. Its chief executive, as recorded, is Sundeep Aurora. Its Indian entity Bioplus Life Sciences Private Limited reported revenue of βΉ143 Cr. Bioplus Life Sciences offers products and services including 7-MX and Nutraceutical Products. Its focus areas include Pharmaceuticals and Ophthalmology Drugs.
Company details
Bioplus Life Sciences is focused on the development of innovative therapeutics for global unmet medical needs, particularly in ophthalmology. The company is involved in research and development of novel drugs like 7-MX for pediatric myopia control. Additionally, solutions are provided in nutraceuticals and dietary supplements. Operations span across clinical and pre-clinical stages, with a presence in over 50 countries. Advanced technology and extensive research are utilized to enhance product and service quality in the healthcare sector.
- Headquarters Bengaluru, India
- Employees 553
- Founders Sundeep Aurora
- Stage Minicorn
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website bioplus.in
- Social LinkedIn X Facebook
- Legal Name Bioplus Life Sciences
- Date of Incorporation 19 Mar, 2004
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹143 Cr
FY 2025 · +46% YoY
- Net Profit₹26.44 Cr
FY 2025 · 9% margin
- EBITDA₹37.32 Cr
FY 2025 · 13% margin
- Total Equity Funding$29.37M (USD)
in 1 rounds
- Latest Funding Round$29.37M (USD), Series B
Jun 2008
- Investors
- Employee Count553
Associated legal entities of Bioplus Life Sciences
Bioplus Life Sciences operates through Bioplus Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bioplus Life Sciences Private Limited CIN U24232KA2004PTC033578 | Active | 19 Mar 2004 | Bangalore, Karnataka | ₹143 Cr | 276 | 4 | View details |
Products & Services of Bioplus Life Sciences
Bioplus Life Sciences offers a comprehensive portfolio of products and services, including 7-MX and Nutraceutical Products.
Developed for pediatric myopia control as therapeutic solution.
Formulated to support health through innovative food ingredients.
Funding Insights of Bioplus Life Sciences
Bioplus Life Sciences has successfully raised a total of $29.37M through 1 strategic funding round. The most recent funding activity was a Series B round of $29.37 million completed in June 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $29.37M
- Total Rounds 1
- Last Round Series B β $29.37M
- First Round $29.37M
(Jun 2008)
- Investors Count 1
All 1 funding rounds of Bioplus Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2008 | $29.37M | Series B | $321.18M | AIF Capital | β |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2008 | $321.18M | β’β’β’β’β’β’β’β’ |
Last known valuation $321.18M (Jun 2008). 1 investors in total: 1 institutional.
Investors in Bioplus Life Sciences
Bioplus Life Sciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include AIF Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment funding and expertise for emerging businesses in Asia. | 1994 | aifcapital.com |
Investor details for Bioplus Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bioplus Life Sciences Private Limited (Bioplus Life Sciences)
Bioplus Life Sciences Private Limited is the primary company behind Bioplus Life Sciences. The board of Bioplus Life Sciences Private Limited currently have 4 directors; the longest-serving is Sundeep Aurora, appointed in 2008. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sundeep Aurora DIN 02244640 | Director | 12 May 2008 | 18 yrs 6 mo | Bioplus Life Sciences Private Limited |
| Sunjeev Aurora DIN 02244616 | Director | 12 May 2008 | 18 yrs 6 mo | Bioplus Life Sciences Private Limited |
| Neha Aurora DIN 07283383 | Additional Director | 29 Oct 2025 | 1 yr | Bioplus Life Sciences Private Limited |
| Rhea Ishani Aurora DIN 11351935 | Additional Director | 29 Oct 2025 | 1 yr | Bioplus Life Sciences Private Limited |
People of Bioplus Life Sciences
2 people are tracked at Bioplus Life Sciences (2 in leadership); the tracked headcount is 553.
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership | |
| Vice President & CFO | Leadership |
Complete people profiles for Bioplus Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Bioplus Life Sciences
Figures of Bioplus Life Sciences Private Limited, the primary company behind Bioplus Life Sciences, for FY 2025. Revenue was ₹143 Cr (+46% year on year). Net profit was ₹26.44 Cr (9% margin). EBITDA was ₹37.32 Cr (13% margin). Revenue has grown at a compounded annual rate of +30% over three years and +12% over five years.
- ₹143 CrRevenue · FY 2025 · +46% YoY
- ₹26.44 CrNet profit · 9% margin
- ₹37.32 CrEBITDA · 13% margin
- ₹3.00 CrPaid-up capital
- 276Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bioplus Life Sciences Private Limited are on its company page.
Detailed financial statements for Bioplus Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Bioplus Life Sciences
3 dated milestones of Bioplus Life Sciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Bioplus Life Sciences is founded.
- Funding First funding round of $29.4M.
- Milestone Reaches Minicorn status.
Web traffic of Bioplus Life Sciences
The website of Bioplus Life Sciences (bioplus.in) receives about 5.9K visits a month and ranks #8,003,749 among all websites worldwide, #7,219 in Biotechnology and Pharmaceuticals.
- Monthly visits5.9K
▲ 230.7% vs previous month
- Global rank#8,003,749
among all websites
- Category rank#7,219
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit2.1
- Average visit41 sec
- DevicesDesktop 45% Β· Mobile 55%
Websites whose visitors overlap most with Bioplus Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bioplusrx.com | 100% | 21.6K | #1,353,684 | View details | |
srico-labworld.com | srico-labworld.com | 63% | #12,069,669 | β | |
biochain.in | biochain.in | 60% | #8,779,875 | β |
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Bioplus Life Sciences (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 72.52 M | 1,115 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bioplus Life Sciences
Complete news archive for Bioplus Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioplus Life Sciences
Bioplus Life Sciences was founded in 2004 and raised its 1st funding round 4 years after it was founded.
Bioplus Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Sundeep Aurora is the CEO of Bioplus Life Sciences, as recorded in our data. They have also founded this company.
Bioplus Life Sciences is a funded company, having raised a total of $29.37M across 1 funding round to date. The company's 1st funding round was a Series B of $29.37M, raised on Jun 2008.
Bioplus Life Sciences has 553 employees.
The primary company behind Bioplus Life Sciences, Bioplus Life Sciences Private Limited, reported revenue of βΉ143 Cr for FY 2025, up 46% year on year.
Bioplus Life Sciences is focused on the development of innovative therapeutics for global unmet medical needs, particularly in ophthalmology. The company is involved in research and development of novel drugs like 7-MX for pediatric myopia control. Additionally, solutions are provided in nutraceuticals and dietary supplements. Operations span across clinical and pre-clinical stages, with a presence in over 50 countries. Advanced technology and extensive research are utilized to enhance product and service quality in the healthcare sector.
Bioplus Life Sciences offers 7-MX and Nutraceutical Products.
Bioplus Life Sciences has 1 investor. Key investors include AIF Capital.
The valuation of Bioplus Life Sciences is $321.18M as of Jun 2008.
Bioplus Life Sciences operates through Bioplus Life Sciences Private Limited.
The legal entities of Bioplus Life Sciences currently have 4 directors, including Neha Aurora, Sundeep Aurora, Sunjeev Aurora and others.
